Assessment of clinical performance of an ultrasensitive nanowire assay for detecting human papillomavirus DNA in urine
Authors:
- 1 March 2020
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 156 (3) , 641-646
Abstract
No abstract availableKeywords
Funding Information
- Korea Health Industry Development Institute
- National Research Foundation of Korea
This publication has 28 references indexed in Scilit:
- Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysisThe Lancet Oncology, 2014
- Comparison of Human Papillomavirus Detections in Urine, Vulvar, and Cervical Samples from Women Attending a Colposcopy ClinicJournal of Clinical Microbiology, 2014
- Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical CancerVaccine, 2012
- Human Papillomavirus Mutational Insertion: Specific Marker of Circulating Tumor DNA in Cervical Cancer PatientsPLOS ONE, 2012
- Diseases caused by human papillomaviruses (HPV)JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2009
- Urine versus brushed samples in human papillomavirus screening: study in both gendersAsian Journal of Andrology, 2007
- Conventional Pap smear and liquid based cytology for cervical cancer screening - a comparative studyJournal of Cytology, 2007
- Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysisThe Lancet, 2005
- Improved Method for Isolating Cell-Free DNAClinical Chemistry, 2005
- Human Papillomavirus and Cervical CancerClinical Microbiology Reviews, 2003